These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28293426)

  • 1. Identification of potential serum biomarkers for breast cancer using a functional proteomics technology.
    Wang DL; Xiao C; Fu G; Wang X; Li L
    Biomark Res; 2017; 5():11. PubMed ID: 28293426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Glycolytic Enzyme Activity Analysis from Human Serum with PEP Technology.
    Wang D
    Methods Mol Biol; 2019; 1871():69-81. PubMed ID: 30276732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology.
    Sun Z; Chen X; Wang G; Li L; Fu G; Kuruc M; Wang X
    Biomark Res; 2016; 4():11. PubMed ID: 27252855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bead Based Proteome Enrichment Enhances Features of the Protein Elution Plate (PEP) for Functional Proteomic Profiling.
    Wang X; Davies M; Roy S; Kuruc M
    Proteomes; 2015 Dec; 3(4):454-466. PubMed ID: 28248280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
    Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
    J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search for breast cancer-related biomarker proteins for drug discovery].
    Nagano K
    Yakugaku Zasshi; 2010 Dec; 130(12):1701-6. PubMed ID: 21139398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
    Fredolini C; Pathak KV; Paris L; Chapple KM; Tsantilas KA; Rosenow M; Tegeler TJ; Garcia-Mansfield K; Tamburro D; Zhou W; Russo P; Massarut S; Facchiano F; Belluco C; De Maria R; Garaci E; Liotta L; Petricoin EF; Pirrotte P
    Breast Cancer Res; 2020 Dec; 22(1):135. PubMed ID: 33267867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics of Sentinel Lymph Nodes in Early Breast Cancer for Identification of Thymidylate Synthase as a Potential Biomarker to Flag Metastasis: A Preliminary Study.
    Pathania S; Khan MI; Kumar A; Gupta AK; Rani K; Ramesh Parashar T; Jayaram J; Ranjan Mishra P; Srivastava A; Mathur S; Hari S; Hariprasad G
    Cancer Manag Res; 2020; 12():4841-4854. PubMed ID: 32606973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
    Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
    OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of Antibody Proteomics Technology for Rapid and Comprehensive Identification of Potential Biomarkers and Therapeutic Targets.
    Nagano K
    Biol Pharm Bull; 2018; 41(5):663-669. PubMed ID: 29709904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate serum biomarkers of childhood-onset growth hormone deficiency using SWATH-MS and feature selection.
    Ortea I; Ruiz-Sánchez I; Cañete R; Caballero-Villarraso J; Cañete MD
    J Proteomics; 2018 Mar; 175():105-113. PubMed ID: 29317355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets.
    Kulasingam V; Diamandis EP
    Mol Cell Proteomics; 2007 Nov; 6(11):1997-2011. PubMed ID: 17656355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.
    Zeidan B; Manousopoulou A; Garay-Baquero DJ; White CH; Larkin SET; Potter KN; Roumeliotis TI; Papachristou EK; Copson E; Cutress RI; Beers SA; Eccles D; Townsend PA; Garbis SD
    Breast Cancer Res; 2018 Mar; 20(1):19. PubMed ID: 29566726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
    Zhang F; Chen JY
    BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.
    Mangé A; Dimitrakopoulos L; Soosaipillai A; Coopman P; Diamandis EP; Solassol J
    J Proteomics; 2016 Jun; 142():114-21. PubMed ID: 27168011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
    Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
    Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.